| In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology Y MATSUMOTO, M KURODA, R MATSUYA, H KATO, K SHIBUYA, ... Oncology reports 22 (3), 641-648, 2009 | 78 | 2009 |
| Robotically driven CT-guided needle insertion: preliminary results in phantom and animal experiments T Hiraki, T Kamegawa, T Matsuno, J Sakurai, Y Kirita, R Matsuura, ... Radiology 285 (2), 454-461, 2017 | 58 | 2017 |
| A Novel PET Imaging Using 64Cu‐Labeled Monoclonal Antibody against Mesothelin Commonly Expressed on Cancer Cells K Kobayashi, T Sasaki, F Takenaka, H Yakushiji, Y Fujii, Y Kishi, S Kita, ... Journal of immunology research 2015 (1), 268172, 2015 | 39 | 2015 |
| Robotic insertion of various ablation needles under computed tomography guidance: accuracy in animal experiments T Hiraki, T Matsuno, T Kamegawa, T Komaki, J Sakurai, R Matsuura, ... European journal of radiology 105, 162-167, 2018 | 35 | 2018 |
| A new phantom using polyethylene glycol as an apparent diffusion coefficient standard for MR imaging R Matsuya, M Kuroda, Y Matsumoto, H Kato, H Matsuzaki, J Asaumi, ... International journal of oncology 35 (4), 893-900, 2009 | 30 | 2009 |
| Spinal epidural empyema in a cat N Maeta, T Kanda, T Sasaki, T Morita, T Furukawa Journal of feline medicine and surgery 12 (6), 494-497, 2010 | 24 | 2010 |
| Synthesis of 11C-labeled RXR partial agonist 1-[(3, 5, 5, 8, 8-pentamethyl-5, 6, 7, 8-tetrahydronaphthalen-2-yl) amino] benzotriazole-5-carboxylic acid (CBt-PMN) by direct [11C … O Shibahara, M Watanabe, S Yamada, M Akehi, T Sasaki, A Akahoshi, ... Journal of medicinal chemistry 60 (16), 7139-7145, 2017 | 23* | 2017 |
| Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists T Kobayashi, Y Furusawa, S Yamada, M Akehi, F Takenaka, T Sasaki, ... ACS Medicinal Chemistry Letters 6 (3), 334-338, 2015 | 19 | 2015 |
| A purification system for 64Cu produced by a biomedical cyclotron for antibody PET imaging T Toyota, T Hanafusa, T Oda, I Koumura, T Sasaki, E Matsuura, H Kumon, ... Journal of Radioanalytical and Nuclear Chemistry 298, 295-300, 2013 | 19 | 2013 |
| Anti-high mobility group box 1 antibody ameliorates albuminuria in MRL/lpr lupus-prone mice H Watanabe, KS Watanabe, K Liu, S Hiramatsu, S Zeggar, E Katsuyama, ... Molecular therapy Methods & clinical development 6, 31-39, 2017 | 16 | 2017 |
| In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β2-glycoprotein I complexes into atherosclerotic plaques of WHHL rabbits … T Sasaki, K Kobayashi, S Kita, K Kojima, H Hirano, L Shen, F Takenaka, ... Autoimmunity Reviews 16 (2), 159-167, 2017 | 12 | 2017 |
| Novel single‐chain variant of antibody against mesothelin established by phage library H Yakushiji, K Kobayashi, F Takenaka, Y Kishi, M Shinohara, M Akehi, ... Cancer science 110 (9), 2722-2733, 2019 | 10 | 2019 |
| In Vitro Assessment of Factors Affecting the Apparent Diffusion Coefficient of Ramos Cells Using Bio-phantoms T Sasaki, M Kuroda, K Katashima, M Ashida, H Matsuzaki, J Asaumi, ... Acta Medica Okayama 66 (3), 263-270, 2012 | 10 | 2012 |
| An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models E Urano, Y Itoh, T Suzuki, T Sasaki, J Kishikawa, K Akamatsu, Y Higuchi, ... Science translational medicine 15 (711), eadi2623, 2023 | 9 | 2023 |
| In vitro assessment of factors affecting the apparent diffusion coefficient of Jurkat cells using bio-phantoms K Katashima, M Kuroda, M Ashida, T Sasaki, T Taguchi, H Matsuzaki, ... Acta Medica Okayama 67 (6), 359-367, 2013 | 8 | 2013 |
| A Novel 89Zr-labeled DDS Device Utilizing Human IgG Variant (scFv): “Lactosome” Nanoparticle-Based Theranostics for PET Imaging and Targeted Therapy MSH Lim, T Ohtsuki, F Takenaka, K Kobayashi, M Akehi, H Uji, H Kobuchi, ... Life 11 (2), 158, 2021 | 7 | 2021 |
| Mutants of β2-glycoprotein I: their features and potent applications L Shen, NU Azmi, XW Tan, S Yasuda, AT Wahyuningsih, J Inagaki, ... Best Practice & Research Clinical Rheumatology 32 (4), 572-590, 2018 | 5 | 2018 |
| Endogenous Leu332Gln mutation in p53 disrupts the tetramerization ability in a canine mammary gland tumor cell line K Ochiai, D Azakami, M Morimatsu, H Hirama, S Kawakami, T Nakagawa, ... Oncology reports 40 (1), 488-494, 2018 | 5 | 2018 |
| The canine RAD51 mutation leads to the attenuation of interaction with PALB2 M Uemura, K Ochiai, M Morimatsu, M Michishita, E Onozawa, D Azakami, ... Veterinary and comparative oncology 18 (2), 247-255, 2020 | 4 | 2020 |
| Fluorine-18 (18F)-labeled retinoid X receptor (RXR) partial agonist whose tissue transferability is affected by other RXR ligands Y Takamura, O Shibahara, M Watanabe, M Fujihara, S Yamada, M Akehi, ... Bioorganic & Medicinal Chemistry 27 (14), 3128-3134, 2019 | 3 | 2019 |
